TP53 and cancer: SIRT6 also promotes the inhibition of the expression of tumor suppressors p53 and FOXO3a [191] and participates in the suppression of AMP-activated protein kinase (AMPK) signaling, which ultimately leads to the survival and proliferation of cancer cells [192].